Effects of Neural Gliding Addes to ESWT and Standard Exercise in Plantar Fasciitis (NG-PF)
Investigation of the Effects of Neural Gliding Exercises Added to Extracorporeal Shock Wave Therapy and Standard Exercise Treatment in Individuals With Plantar Fasciitis
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This randomized controlled trial was conducted to investigate the effects of neural gliding exercises added to extracorporeal shock wave therapy and standard exercise treatment in individuals with plantar fasciitis. A total of 56 participants diagnosed with plantar fasciitis were included in the study and randomly assigned into two groups.
The first group received extracorporeal shock wave therapy combined with a standard exercise program. The second group received extracorporeal shock wave therapy, the same standard exercise program, and additional neural gliding exercises.
Extracorporeal shock wave therapy was applied once weekly for five weeks, with 2000 impulses per session. Participants were instructed to perform their home exercise program twice daily for five weeks.
Outcome measures included pain intensity, foot function, muscle flexibility, balance performance, walking-related functional performance, muscle strength, heel raise performance, and physical activity level. Assessments were performed before and after the intervention period.
The aim of this study was to determine whether adding neural gliding exercises to conventional treatment provides additional clinical benefit in individuals with plantar fasciitis.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Ankara
-
Ankara, Ankara, Turkiet (Türkiye), 06010
- University of Health Sciences Gulhane Training and Research Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Diagnosed with plantar fasciitis
- Aged between 18 and 60 years
- Male or female participants
- Willing to participate voluntarily in the study
- Able to comply with treatment and evaluation procedures
Exclusion Criteria:
- Lack of cooperation or inability to follow instructions
- Presence of systemic or metabolic disease
- Malignancy, osteoporosis, fracture, coagulation disorders, active infection, or pacemaker implantation
- Pregnancy
- Receiving any other treatment for plantar fasciitis during the study period
- Having received treatment for plantar fasciitis within the last 6 months
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: ESWT + Standart Exercise
Participants received extracorporeal shock wave therapy once weekly for 5 weeks (2000 pulses/session) in addition to a standard home exercise performed twice daily for 5 weeks.
|
Extracorporeal Shock Wave Therapy was applied once weekly for 5 weeks, with 2000 pulses per session.
Participants performed a standardized home exercise program twice daily for 5 weeks, 10 repetitions for each exercise session.
|
|
Experimentell: ESWT + Standard Exercise + Neural Gliding
Participants received extracorporeal shock wave therapy once weekly for 5 weeks (2000 pulse/sessions), a standard home exercise program twice daily and additional neural gliding exercise for 5 weeks.
|
Extracorporeal Shock Wave Therapy was applied once weekly for 5 weeks, with 2000 pulses per session.
Participants performed a standardized home exercise program twice daily for 5 weeks, 10 repetitions for each exercise session.
Participants performed neural gliding exercises as an adjunct to the standard exercise program for 5 weeks.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pain Intensity (Visual Analog Scale, VAS)
Tidsram: Baseline and Week 5
|
Pain intensity will be assessed using the Visual Analog Scale (VAS) before treatment and after 5 weeks of invertion.
|
Baseline and Week 5
|
|
Foot Function Index (FFI)
Tidsram: Baseline and Week 5
|
Foot related pain, disabilitya and activity limitation will be evaluated using the Foot Function Index before treatment and after 5 weeks.
|
Baseline and Week 5
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Muscle Shortness Assessment
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
|
Single Leg Stance Test
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
|
Heel Raise Test
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
|
One Step Walking Test
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
|
Muscle Strength Assessment
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
|
International Physical Activity Questionnaire (IPAQ)
Tidsram: Baseline and Week 5
|
Baseline and Week 5
|
Samarbetspartners och utredare
Samarbetspartners
Publikationer och användbara länkar
Allmänna publikationer
- Yıldız B., Akınoğlu B. Effectiveness of neural gliding exercises combined with extracorporeal shock wave therapy and standad exercise program in individuals with plantar fasciitis: randomized controlled trial protocol. Ankara, Turkiye, 2026.
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- AYBU-PF-2026-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .